The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: A large study from a single institution

Upcoming publication from the British Journal of Cancer, investigating HER2 expression as a predictor of recurrence and development in patients with DCIS.
Source: EurekaAlert, https://www.eurekalert.org